Li C, Li Q, Mei Q, et al. Pharmacological effects and pharmacokinetic properties of icariin, the major bioactive component in Herba Epimedii[J]. Life Sci,2015, 126(7): 57-68.
[7]
Zhang L, Wang S, Li Y, et al. Cardioprotective effect of icariin against myocardial fibrosis and its molecular mechanism in diabetic cardiomyopathy based on network pharmacology: role of ICA in DCM[J]. Phytomedicine,2021, 91(9): 153607.
Luo P, Chen C, Lu Y, et al. Baclofen ameliorates spatial working memory impairments induced by chronic cerebral hypoperfusion via up-regulation of HCN2 expression in the PFC in rats[J]. Behav Brain Res,2016, 308(6): 6-13.
Kumar D K, Choi S H, Washicosky K J, et al. Amyloid-beta peptide protects against microbial infection in mouse and worm models of Alzheimer’s disease[J]. Sci Transl Med,2016, 8(340): 340-372.
[12]
Stancu I C, Ferraiolo M, Terwel D, et al. Tau Interacting Proteins: gaining insight into the roles of tau in health and disease[J]. Adv Exp Med Biol,2019, 84(11): 145-166.
[13]
Yang R Y, Zhao G, Wang D M, et al. DL0410 can reverse cognitive impairment, synaptic loss and reduce plaque load in APP/PS1 transgenic mice[J]. Pharmacol Biochem Behav,2015, 139(Pt A): 15-26.
[14]
Zhang L, Shen C, Chu J, et al. Icariin decreases the expression of APP and BACE-1 and reduces the beta-amyloid burden in an APP transgenic mouse model of Alzheimer’s disease[J]. Int J Biol Sci,2014, 10(2): 181-191.
[15]
Zhang D, Wang Z, Sheng C, et al. Icariin Prevents Amyloid Beta-Induced Apoptosis via the PI3K/Akt Pathway in PC-12 Cells[J]. Evid Based Complement Alternat Med,2015,2015: 235265.
[16]
Li X A, Ho Y S, Chen L, et al. The Protective effects of icariin against the homocysteine-induced neurotoxicity in the primary embryonic cultures of rat cortical neurons[J]. Molecules,2016, 21(11):245-252.
[17]
Yin C, Deng Y, Liu Y, et al. Icariside II Ameliorates cognitive impairments induced by chronic cerebral hypoperfusion by inhibiting the amyloidogenic pathway: involvement of BDNF/TrkB/CREB signaling and up-regulation of PPARalpha and PPARgamma in rats[J]. Front Pharmacol,2018, 19(6): 1211.
[18]
Yan L, Deng Y, Gao J, et al. Icariside II effectively reduces spatial learning and memory impairments in Alzheimer’s disease model mice targeting beta-amyloid production[J]. Front Pharmacol,2017, 25(8): 106.
[19]
Li Y Y, Huang N Q, Feng F, et al. Icaritin improves memory and learning ability by decreasing bace-1 expression and the Bax/Bcl-2 ratio in senescence-accelerated mouse prone 8 (SAMP8) mice[J]. Evid Based Complement Alternat Med,2020:8963845.
[20]
Bettcher B M, Kramer J H. Longitudinal inflammation, cognitive decline, and Alzheimer’s disease: a mini-review[J]. Clin Pharmacol Ther,2014, 96(4): 464-469.
[21]
Zhang J, Song N, Liu Y, et al. Platycodin D Inhibits beta-amyloid-induced inflammation and oxidative stress in BV-2 cells via suppressing TLR4/NF-kappaB signaling pathway and activating Nrf2/HO-1 signaling pathway[J]. Neurochem Res,2021, 46(3): 638-647.
[22]
Guo J, Li F, Wu Q, et al. Protective effects of icariin on brain dysfunction induced by lipopolysaccharide in rats[J]. Phytomedicine,2010, 17(12): 950-955.
[23]
Deng Y, Long L, Wang K, et al. Icariside II, a broad-spectrum anti-cancer agent, reverses beta-amyloid-induced cognitive impairment through reducing inflammation and apoptosis in rats[J]. Front Pharmacol,2017, 25(8): 39.
[24]
Zhou J, Deng Y, Li F, et al. Icariside II attenuates lipopolysaccharide-induced neuroinflammation through inhibiting TLR4/MyD88/NF-kappaB pathway in rats[J]. Biomed Pharmacother,2019, 111(6): 315-324.
[25]
Zheng Y, Deng Y, Gao J M, et al. Icariside II inhibits lipopolysaccharide-induced inflammation and amyloid production in rat astrocytes by regulating IKK/IkappaB/NF-kappaB/BACE1 signaling pathway[J]. Acta Pharmacol Sin,2020, 41(2): 154-162.
Barros L A, Tufik S, Andersen M L. The role of progesterone in memory;an overview of three decades[J]. Neurosci Biobehav Rev,2015, 49(8): 193-204.
[28]
Jackson A C, Roche S L, Byrne A M, et al. Progesterone receptor signalling in retinal photoreceptor neuroprotection[J]. J Neurochem,2016, 136(1): 63-77.
Kim S M, Hwang I K, Yoo D Y, et al. Tat-antioxidant 1 protects against stress-induced hippocampal HT-22 cells death and attenuate ischaemic insult in animal model[J]. J Cell Mol Med. 2015, 19(6): 1333-1345.
Feng L, Gao J, Liu Y, et al. Icariside II alleviates oxygen-glucose deprivation and reoxygenation-induced PC12 cell oxidative injury by activating Nrf2/SIRT3 signaling pathway[J]. Biomed Pharmacother,2018, 103(9): 9-17.
[35]
Gao J, Deng Y, Yin C, et al. Icariside II, a novel phosphodiesterase 5 inhibitor, protects against H2 O2 -induced PC12 cells death by inhibiting mitochondria-mediated autophagy[J]. J Cell Mol Med,2017, 21(2): 375-386.
Zhang W, Xing B, Yang L, et al. Icaritin attenuates myocardial ischemia and reperfusion injury via anti-inflammatory and anti-oxidative stress effects in rats[J]. Am J Chin Med,2015, 43(6): 1083-1097.
[38]
Guo C, Zhang Y X, Wang T, et al. Intranasal deferoxamine attenuates synapse loss via up-regulating the P38/HIF-1alpha pathway on the brain of APP/PS1 transgenic mice[J]. Front Aging Neurosci,2015, 7: 104.
[39]
Meadowcroft M D, Peters D G, Dewal R P, et al. The effect of iron in MRI and transverse relaxation of amyloid-beta plaques in Alzheimer’s disease[J]. NMR Biomed,2015, 28(3): 297-305.
2022, Vol. 33 
